4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-21-057527
Chief Operating Officer sold 2,451 shares at $17.22 ($42,206)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2021-09-23 | Sale | −2,451 | $17.22 | $42,206 | 33,453 | D |
| Open-market sales · 2,451 sh · avg $17.22 · $42,206 | |||||||
Loading xslF345X03/doc4.xml…